Silk Road Medical, Inc
NASDAQ:SILK
27.49 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 20.21 | 55.358 | 110.231 | 69.466 | 39.181 | 24.99 | 33.331 |
| Short Term Investments
| 161.264 | 158.316 | 0 | 78.016 | 51.508 | 0 | 0 |
| Cash and Short Term Investments
| 181.474 | 213.674 | 110.231 | 147.482 | 90.689 | 24.99 | 33.331 |
| Net Receivables
| 23.573 | 18.007 | 11.832 | 9.07 | 8.601 | 4.52 | 5.215 |
| Inventory
| 29.876 | 19.293 | 17.851 | 9.989 | 10.322 | 5.744 | 3.248 |
| Other Current Assets
| 5.912 | 3.924 | 3.412 | 6.787 | 2.878 | 1.408 | 0.279 |
| Total Current Assets
| 240.835 | 254.898 | 143.326 | 173.328 | 112.49 | 36.662 | 42.073 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 14.603 | 9.372 | 7.697 | 2.844 | 2.734 | 2.88 | 0.486 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0.075 | 0.061 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0.075 | 0.061 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 9.456 | 0.155 | 0.232 | 0.31 | 18.224 | 0.31 | 0.51 |
| Tax Assets
| 0 | -0.155 | -0.293 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.415 | 5.34 | 5.602 | 2.832 | 3.954 | 1.029 | 0.017 |
| Total Non-Current Assets
| 24.474 | 14.787 | 13.299 | 5.986 | 24.912 | 4.219 | 1.013 |
| Total Assets
| 265.309 | 269.685 | 156.625 | 179.314 | 137.402 | 40.881 | 43.086 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 5.676 | 2.523 | 2.379 | 2.598 | 1.898 | 1.252 | 1.546 |
| Short Term Debt
| 1.703 | 1.844 | 3.905 | 0.85 | 0.769 | -0.137 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.143 | 0.253 | 0.157 | 0.206 | 0.304 | 0.137 | 0 |
| Other Current Liabilities
| 22.761 | 19.868 | 19.645 | 15.901 | 13.961 | 7.586 | 3.109 |
| Total Current Liabilities
| 30.283 | 24.488 | 26.086 | 19.555 | 16.932 | 8.838 | 4.655 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 75.626 | 74.596 | 44.786 | 48.533 | 44.879 | 44.201 | 27.589 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 8.249 | 6.726 | 6.513 | 3.726 | 3.7 | 1.069 | 109.42 |
| Total Non-Current Liabilities
| 83.875 | 81.322 | 51.299 | 52.259 | 48.579 | 45.27 | 137.009 |
| Total Liabilities
| 114.158 | 105.81 | 77.385 | 71.814 | 65.511 | 54.108 | 141.664 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 105.235 | 105.235 |
| Common Stock
| 0.039 | 0.038 | 0.035 | 0.034 | 0.031 | 0.024 | 0.001 |
| Retained Earnings
| -399.455 | -343.712 | -288.702 | -238.891 | -191.526 | -139.111 | -101.556 |
| Accumulated Other Comprehensive Income/Loss
| 0.072 | -0.166 | 0 | 0.039 | 0.002 | -0.946 | -1.303 |
| Other Total Stockholders Equity
| 550.495 | 507.715 | 367.907 | 346.318 | 263.384 | 21.571 | -100.955 |
| Total Shareholders Equity
| 151.151 | 163.875 | 79.24 | 107.5 | 71.891 | -13.227 | -98.578 |
| Total Equity
| 151.151 | 163.875 | 79.24 | 107.5 | 71.891 | -13.227 | -98.578 |
| Total Liabilities & Shareholders Equity
| 265.309 | 269.685 | 156.625 | 179.314 | 137.402 | 40.881 | 43.086 |